Wells Fargo & Company Htg Molecular Diagnostics, Inc Transaction History

Wells Fargo & Company

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.62 - $1.89 $2 - $7	-4 Reduced 8.0%	46 $0
Q2 2022 Aug 12, 2022	BUY	$0.46 - $1.45 $4 - $13	9 Added 21.95%	50 $0
Q1 2022 May 16, 2022	BUY	$1.39 - $5.51 $1 - $5	1 Added 2.5%	41 $0
Q4 2021 Feb 14, 2022	BUY	$3.23 - $5.97 $3 - $5	1 Added 2.56%	40 $0
Q3 2021 Nov 15, 2021	BUY	$5.01 - $6.8 $10 - $13	2 Added 5.41%	39 $0
Q2 2021 Aug 16, 2021	BUY	$3.52 - $5.98 $31 - $53	9 Added 32.14%	37 $0
Q1 2021 May 13, 2021	BUY	$4.99 - $7.83 $9 - $15	2 Added 7.69%	28 $0
Q4 2020 Feb 09, 2021	BUY	$4.14 - $5.95 $107 - $154	26 New	26 $0

Ticker HTGM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 11,048,100
Market Cap $3.76M
Description
HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables comprising assay kits; and software that automate sample processing and profiles various molecular targets. Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG EdgeSeq precision immuno-o...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.